2-year (base year & 1 option year), firm fixed price (FFP) task order for senior executive public speaking training supporting the office of external affairs (OEA), in partnership with the office of…

Active Awarded Last action

Contract number
75F40126F19041
Awardee
Awarding agency
Obligated
$98,034

Award facts

Contract value 49% obligated
  • $98,034.00 Current, with exercised options
  • $199,096.80 Potential, with all options
Completion date 4% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
Competitive 8(a)
Competition
Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration issued a $199,096.80 delivery order to Kaiva Strategies, LLC on September 30, 2026, under the Competitive 8(a) Professional, Administrative, and Consulting Services (PACS) IDIQ for senior executive public speaking training supporting the Office of External Affairs in partnership with the Office of Training, Education, and Development.

The PACS IDIQ is a $100 million Competitive 8(a) single-award vehicle running through August 2028. This firm fixed price order carries a ceiling value of $199,096.80 with an ultimate completion date of September 29, 2028. Place of performance is Silver Spring, MD.

Kaiva Strategies, LLC is a tribally-owned, minority-owned 8(a) small business headquartered in Ivins, Utah. The company operates as a managed service delivery vehicle, with subcontractors performing an average of 70 percent of contractor hours across its SCI-reportable prime contracts.

Description

2-year (base year & 1 option year), firm fixed price (FFP) task order for senior executive public speaking training supporting the office of external affairs (OEA), in partnership with the office of training, education, and development (oted)

Quick answers

Who was awarded contract 75F40126F19041?

75F40126F19041 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.

How much is contract 75F40126F19041 worth?

The government has obligated $98,034 on 75F40126F19041. Its potential value, with all options, is $199,097.

Is contract 75F40126F19041 an order under another contract?

Yes. 75F40126F19041 is a delivery order under 75F40123D00021, an indefinite delivery contract.

Was contract 75F40126F19041 competed?

The extent of competition for 75F40126F19041 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award